Genomic, biochemical, and cellular drivers of brain tumor heterogeneity and evolution. Cancer predisposition syndromes. Response and resistance to treatment.
San Francisco, CA
Joined March 2020
- Tweets451
- Following323
- Followers885
- Likes1.2K
Pinned Tweet
Wonderful to see this work published, which establishes a new prospective, consecutive benchmark for the population prevalence of molecular alterations in #meningioma. Critical for design of molecularly-guided clinical trials. @UCSFRadOnc @UCSF @UCSFCancer @NeurosurgUCSF
In a new @JAMAOnc study, @LabRaleigh and colleagues report the results from a prospective genomic profiling analysis of more than 1100 meningiomas. Their findings could help guide evolving diagnostic criteria and clinical trial design: jamanetwork.com/journals/jam…
@UCSFRadOnc
ALT Graphic showing an MRI scan of a meningioma. Text banner with the publication citation reads, Prospective Genomic Profiling of Consecutive Meningiomas. Nguyen MP, Mirchia K, Braman BC, et al. (2026) JAMA Oncol.
RaleighLab retweeted
We have waited more than a decade for this: ROAM is presented in Rome #EANO2026! See the results of ROAM/EORTC-1308, now also published in @TheLancet!
@EANOassociation
thelancet.com/journals/lance…
RaleighLab retweeted
Genomic profiling of consecutive meningiomas found associations between copy number alterations, somatic variants, tumor grade, and patient characteristics, offering insights into prognosis and therapeutic vulnerability. ja.ma/4uVcbiW
Played a small part in this important study where @FelixEhretMD did the heavy lifting. @UCSFRadOnc @UCSF @UCSFCancer @NeurosurgUCSF
What is the role of reirradiation for recurrent meningioma? Read our systematic review and meta‑analysis in @Advances_ASTRO!
@ASTRO_org @ESTRO_RT @LabRaleigh @joostverhoeff
advancesradonc.org/article/S…
RaleighLab retweeted
Read the new research letter in @JAMAOnc that reports findings from prospective #genomic profiling of 1104 consecutive #meningiomas:
jamanetwork.com/journals/jam…
@LabRaleigh
RaleighLab retweeted
Excited to see outstanding @UCSF work @ #AACR2026! Brooke Braman @LabRaleigh 2 posters genomics/meningiomas, Courtney Tamaka (Nam Woo Cho Lab) radiation-inducible surface protein targets /tumor microenvironment @UCSFHospitals @NeurosurgUCSF @AACR Details linkedin.com/posts/ucsf-radi…
New paper on targeting the #glioblastoma immune microenvironment from an "old" @LabRaleigh postdoc @jakeyoung11, who now has his own lab at @NeurosurgUCSF !! Reach out to him to collaborate or learn more! @UCSFCancer @UCSFRadOnc @UCSF
pubmed.ncbi.nlm.nih.gov/4197…
It was an honor and a privilege to visit @ErasmusMC today and talk about #meningioma with so many leaders in neuro-oncology! @NeurosurgUCSF @UCSFRadOnc @UCSFCancer @UCSF
Very excited to work with @NRGonc in this position!
Congratulations to David @LabRaleigh on being appointed Translational Science Co-Vice Chair of the NRG Brain Tumor Committee! @NeurosurgUCSF @UCSF @NRGonc
Brooke Braman from @LabRaleigh presenting on her development of a gene expression biomarker to identify #glioblastoma that benefit from re-irradiation at #sno2025. @NRGOncology @NeurosurgUCSF @UCSFRadOnc @UCSF @UCSFCancer
Zora Arum from @LabRaleigh presenting on the development and implementation of a comprehensive, multidisciplinary #meningioma program at #sno2025. @NeurosurgUCSF @UCSFRadOnc @UCSF @UCSFCancer
Such a delight to present #meningioma work from Drs. Minh Nguyen and Brooke Braman from @LabRaleigh at #SNO2025
David Raleigh, MD, PhD, presenting data from @LabRaleigh on genomic profiling of over 1000 consecutive, prospective meningiomas to a full house at #SNO2025. Understanding the molecular alterations of these tumors is leading to better biomarkers of treatment response.
New from @LabRaleigh and @TimCaseyClyde in @eLife: Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest doi.org/10.7554/eLife.100159
Pleasure to write this editorial about an innovative and important new clinical trial for meningioma. @NeurosurgUCSF @UCSFCancer @UCSF @UCSFRadOnc
Rational radionuclide therapy for recurrent meningioma. ow.ly/L5WP50Xif7k
#NuclearMedicine #RPTherapy #Meningioma @LabRaleigh
RaleighLab retweeted
Truly honored to have been part of this exciting work alongside an amazing team led by Dr. Alex Haddad, @ManishKAghi, and @LabRaleigh. Read the full paper here! (4/4)
@UCSF @UCSFCancer #neurosurgery #neurooncology #meningioma
academic.oup.com/neuro-oncol…
RaleighLab retweeted
Grateful to the many teams who supported this work, championed by Karenna Groff. As we uncover more biomarkers of tumor behavior, implementation into clinical practice merits close introspection of context. @MGBneurosurgery @LabRaleigh @sahm_lab @MGBCTNS @NYUneurosurgery @RuchitVP
Proud to share our collaborative work, now published in @TheLancetOncol. This project stands as a testament to the talent and enduring spirit of Karenna Groff. Thanks to @wenyalindabi for her dedication in bringing this to publication. @MeningiomaBot authors.elsevier.com/c/1liJQ…
RaleighLab retweeted
One of the most discussed topics in neurosurgery: The Rationale for Early Adjuvant Radiotherapy After Gross... : Neurosurgery journals.lww.com/neurosurger…
Very happy to share Minh Nguyen's paper with @WilliamCChen1 from @LabRaleigh reporting optimized CNA size thresholds and co-occurence patterns for individualized risk-stratifictation. @NeurosurgUCSF @UCSFRadOnc @UCSFCancer @UCSF @akashjp330 . nature.com/articles/s41467-0…
One of my favorite things about this paper is that we managed to co-publish with @wenyalindabi who found very similar things for #meningioma! nature.com/articles/s41467-0…